C4 Therapeutics shares surge 14.81% after-hours following announcement of presentation at TD Cowen 46th Annual Healthcare Conference on March 3.

C4 Therapeutics surged 14.81% in after-hours trading following news that the company will present at the TD Cowen 46th Annual Healthcare Conference on March 3. The event, a key platform for healthcare companies to showcase developments and strategic updates, is expected to enhance investor visibility and engagement. By highlighting its progress and participating in a fireside chat, C4 Therapeutics aims to strengthen its market profile, aligning with the stock’s positive after-hours reaction as investors anticipate potential business updates or partnerships.